Solid Biosciences: UBS initiates coverage with buy rating and $20 target price
SLDB•UBS initiated coverage of Solid Biosciences with a buy rating and a $20 target price.
Related News
Sheinbaum says Televisa's AT&T Mexico purchase will help competition
T•
Baker Hughes and Venture Global expand strategic long-term power generation partnership
BKR•
RedCloud announces shareholder meeting to vote on share consolidation
RCT•
Sun Life Financial target price cut to C$123 from C$124
SLF•
Molson Coors Beverage Company: UBS cuts target price to $40 from $45
TAP•